Highest European Court Rules CBD Is Not A Narcotic Drug
Executive Summary
The European Court of Justice rules that CBD cannot be regarded as a narcotic as it is non-psychoactive and suggests that a French ban on the cannabinoid is contrary to EU law on the free movement of goods. Legal experts and industry hope the judgment will pave the way for a regulated European CBD market.
You may also be interested in...
Italy Reclassifies Natural CBD Oil As Medicine Containing Narcotic
Italy reclassifies natural CBD as a narcotic drug. The decision may see challenges from companies marketing in Italy natural CBD supplements registered in other European countries, given that the European Court of Justice (CJEU) overturned a similar position taken by France in 2020.
Sale Of CBD Flower And Leaf Up To 0.3% THC Legal, French High Court Decides
Having no psychotropic effect and not causing addiction, CBD flowers and leaves cannot be considered a narcotic, the French high court rules, delivering its final verdict on last year's ban by the country's Ministry of Solidarity and Health.
CBD Supplements, Teas And Flowers Up To 0.3% THC Allowed In France, For Now
France's Ministry of Solidarity and Health published a decree allowing the commercial sale of cannabis sativa extracts with a maximum THC content up to 0.3%, but banning the sale of raw cannabis flowers and leaves to consumers in all their forms, thus elimating a booming CBD market for tea, for example. The ban, however, has been halted by France's highest administrative court on the basis that it is disproportionate. While the Conseil d’Etat makes its final decision, French bricks-and-mortar and online CBD retailers can continue selling low-THC cannabis flowers and leaves.